This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Expansion Of Medical Marijuana Acceptance Across The USA Progresses With Massachusetts, Montana (and Arkansas Too Close To Call) Joining 13 Other States

Stocks in this article: PHOT

WOODLANDS HILLS, Calif., Nov. 7, 2012 /PRNewswire/ -- GrowLife, Inc. (OTCBB: PHOT) (formerly known as Phototron Holdings Inc.), an innovative leader in high-end horticulture supply, today announced that it commends the huge step forward taken by votes in Massachusetts and Montana, which have now adopted progressive medical marijuana laws. A similar initiative in Arkansas remains too close to call at press time. These initiatives, combined with the even more progressive legalization measures passed in Colorado and Washington State, will almost certainly compel even wider adoption by other states and progress towards a more reasonable federal policy.  For GrowLife, Inc. ( www.growlifeinc.com) (OTCBB: PHOT) and other public companies that are already active in this multibillion dollar growth industry such as Hemp, Inc. ( www.hemp.com) and Medical Marijuana,Inc. ( www.medicalmarijuana.com) are very likely to see rapidly expanding opportunities as the normalization process marches from state to state, expanding the market and legitimate business opportunities as it grows.

"Marijuana has been shown to be very effective in many different medical scenarios," said GrowLife, Inc. CEO Sterling Scott. "The federal government has long grouped marijuana in the same group as cocaine and heroin, but the reality is that the drug has helped many thousands of people overcome chronic symptoms related to diseases like cancer, glaucoma, AIDS, Crohn's, ALS ( Lou Gehrig's Disease) and Alzheimers among others."

While prescription drugs kill about 100,000 people worldwide each year, there are no deaths associated with cannabis use, according to Dr. Lester Grinspoon, professor emeritus at Harvard Medical School. The late Dr. Tod Mikuriya, former national administrator of the U.S. government's marijuana research programs, also found that about 200 different medical conditions responded favorably to cannabis after seeing about 10,000 patients in 15 years.

Public companies focused on this emerging industry are experiencing rapid expansion as the regulatory environment becomes more favorable. GrowLife, Inc. (PHOT), Hemp Inc. and Medical Marijuana Inc. have all seen heightened attention in recent weeks due to the history making elections that have now been decided in favor of legalization and much expanded purely medical usage applications.  Now that history has been made, these companies are positioned to become even bigger leaders in this sector than they are already, and the investment community has a ready-made opportunity to ride the wave.  These three exceptional companies are being run by acute business men, that while compassionate towards the needs of individuals, are keenly focused on the bottom line, and what that means to their investors.

About GrowLife, Inc.

GrowLife, Inc. (PHOT) (formerly Phototron Holding, Inc.) ( www.growlifeinc.com) (OTCBB: PHOT) is a company with core holdings in innovative technology-based products and services for the indoor gardening industry and specialty markets. These brands include SG producer of grow room automation equipment and  hi-powered LED grow light products for indoor horticulture ( www.sgsensors.com and www.stealthgrow.com), Greners.com, the online hydroponics superstore ( www.greners.com) and Phototron, producer of hydroponic grow containers, which are designed to grow vegetables, herbs, flowers and fruits in any environment ( www.phototron.com).

For more information about our public holding company, please visit  www.growlifeinc.com.

Cautionary Language Concerning Forward-Looking Statements

Information set forth in this press release contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion of factors that may affect future results is contained in GrowLife's filings with the Securities and Exchange Commission. In addition, all  industry products are subject to additional uncertainty, including the risks of delay, cancellation and poor critical or financial reception. GrowLife disclaims any obligation to update and revise statements contained in this news release based on new information or otherwise.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,677.90 +216.58 1.32%
S&P 500 1,950.82 +23.71 1.23%
NASDAQ 4,452.7920 +69.9450 1.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs